Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
Rosenkranz S, Pausch C, Coghlan JG, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Delcroix M, Ghofrani HA, Ewert R, Kabitz HJ, Skowasch D, Behr J, Milger K, Halank M, Wilkens H, Seyfarth HJ, Held M, Scelsi L, Neurohr C, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Eisenmann S, Schmidt KH, Remppis BA, Skride A, Jureviciene E, Gumbiene L, Miliauskas S, Löffler-Ragg J, Lange TJ, Olsson KM, Hoeper MM, Opitz C. Rosenkranz S, et al. Among authors: seyfarth hj. J Heart Lung Transplant. 2023 Jan;42(1):102-114. doi: 10.1016/j.healun.2022.10.003. Epub 2022 Oct 13. J Heart Lung Transplant. 2023. PMID: 36333206 Free article.
Bosentan therapy for portopulmonary hypertension.
Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Hoeper MM, et al. Among authors: seyfarth hj. Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804. Eur Respir J. 2005. PMID: 15738295 Free article.
Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
Hoeper MM, Seyfarth HJ, Hoeffken G, Wirtz H, Spiekerkoetter E, Pletz MW, Welte T, Halank M. Hoeper MM, et al. Among authors: seyfarth hj. Eur Respir J. 2007 Dec;30(6):1096-102. doi: 10.1183/09031936.00032407. Epub 2007 Jul 25. Eur Respir J. 2007. PMID: 17652314 Free article.
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension.
Hoeper MM, Gall H, Seyfarth HJ, Halank M, Ghofrani HA, Winkler J, Golpon H, Olsson KM, Nickel N, Opitz C, Ewert R. Hoeper MM, et al. Among authors: seyfarth hj. Eur Respir J. 2009 Jul;34(1):132-7. doi: 10.1183/09031936.00130408. Epub 2009 Feb 27. Eur Respir J. 2009. PMID: 19251782 Free article. Clinical Trial.
[Chronic thromboembolic pulmonary hypertension--a position paper].
Wilkens H, Lang I, Blankenburg T, Grohé C, Guth S, Held M, Klepetko W, Konstantinides S, Kramm T, Krüger U, Lankeit M, Schäfers HJ, Seyfarth HJ, Mayer E. Wilkens H, et al. Among authors: seyfarth hj. Dtsch Med Wochenschr. 2014 Oct;139(43):2204-6. doi: 10.1055/s-0034-1370219. Epub 2014 Aug 1. Dtsch Med Wochenschr. 2014. PMID: 25084309 German. No abstract available.
[Chronic thromboembolic pulmonary hypertension--a position paper].
Wilkens H, Lang I, Blankenburg T, Grohé C, Guth S, Held M, Klepetko W, Konstantinides S, Kramm T, Krüger U, Lankeit M, Schäfers HJ, Seyfarth HJ, Mayer E. Wilkens H, et al. Among authors: seyfarth hj. Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S155-65. doi: 10.1055/s-0034-1370220. Epub 2014 Aug 1. Dtsch Med Wochenschr. 2014. PMID: 25084310 Review. German.
[Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].
Wilkens H, Konstantinides S, Lang I, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs J, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E. Wilkens H, et al. Among authors: seyfarth hj. Dtsch Med Wochenschr. 2016 Oct;141(S 01):S62-S69. doi: 10.1055/s-0042-114529. Epub 2016 Oct 19. Dtsch Med Wochenschr. 2016. PMID: 27760452 Review. German.
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S; FOCUS Investigators. Valerio L, et al. Among authors: seyfarth hj. Eur Heart J. 2022 Sep 21;43(36):3387-3398. doi: 10.1093/eurheartj/ehac206. Eur Heart J. 2022. PMID: 35484821 Free PMC article.
Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension.
Ewert R, Ittermann T, Schmitt D, Pfeuffer-Jovic E, Stucke J, Tausche K, Halank M, Winkler J, Hoheisel A, Stubbe B, Heine A, Seyfarth HJ, Opitz C, Habedank D, Wensel R, Held M. Ewert R, et al. Among authors: seyfarth hj. J Cardiovasc Dev Dis. 2022 Oct 1;9(10):333. doi: 10.3390/jcdd9100333. J Cardiovasc Dev Dis. 2022. PMID: 36286285 Free PMC article.
112 results